Precision Biosciences Inc 8-K Filing
Ticker: DTIL · Form: 8-K · Filed: Jan 29, 2025 · CIK: 1357874
| Field | Detail |
|---|---|
| Company | Precision Biosciences Inc (DTIL) |
| Form Type | 8-K |
| Filed Date | Jan 29, 2025 |
| Pages | 1 |
| Reading Time | 2 min |
| Key Dollar Amounts | $0.000005 |
| Sentiment | neutral |
Sentiment: neutral
FAQ
What type of filing is this?
This is a 8-K filing submitted by Precision Biosciences Inc (ticker: DTIL) to the SEC on Jan 29, 2025.
What are the key financial figures in this filing?
Key dollar amounts include: $0.000005 (ch registered Common Stock, par value $0.000005 per share DTIL The Nasdaq Capital M).
How long is this filing?
Precision Biosciences Inc's 8-K filing is 1 pages with approximately 440 words. Estimated reading time is 2 minutes.
Where can I view the full 8-K filing?
The complete filing is available on SEC EDGAR. You can also read the AI-decoded analysis with risk assessment and key highlights on ReadTheFiling.
Filing Stats: 440 words · 2 min read · ~1 pages · Grade level 11.1 · Accepted 2025-01-29 07:30:08
Key Financial Figures
- $0.000005 — ch registered Common Stock, par value $0.000005 per share DTIL The Nasdaq Capital M
Filing Documents
- dtil-20250123.htm (8-K) — 49KB
- 0000950170-25-010209.txt ( ) — 164KB
- dtil-20250123.xsd (EX-101.SCH) — 27KB
- dtil-20250123_htm.xml (XML) — 5KB
01 Financial Statements and Exhibits
Item 9.01 Financial Statements and Exhibits. (d) Exhibits Exhibit No. Description 104 Cover Page Interactive Data File (embedded within the Inline XBRL document).
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. PRECISION BIOSCIENCES, INC. Date: January 29, 2025 By: /s/ Dario Scimeca Dario Scimeca General Counsel